|
SLC7A1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.02509999999156E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.169800E-04 |
| Normal-vs-Stage2 |
1.128410E-01 |
| Normal-vs-Stage3 |
3.35480000002164E-06 |
| Normal-vs-Stage4 |
2.621000E-03 |
| Stage1-vs-Stage2 |
6.102000E-01 |
| Stage1-vs-Stage3 |
1.093030E-01 |
| Stage1-vs-Stage4 |
7.027200E-01 |
| Stage2-vs-Stage3 |
1.843790E-01 |
| Stage2-vs-Stage4 |
5.000400E-01 |
| Stage3-vs-Stage4 |
4.187600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.41739999998314E-06 |
| Normal-vs-AfricanAmerican |
4.46990000000369E-05 |
| Normal-vs-Asian |
1.389610E-02 |
| Caucasian-vs-AfricanAmerican |
2.418000E-01 |
| Caucasian-vs-Asian |
6.132800E-01 |
| AfricanAmerican-vs-Asian |
2.040000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.44880000055403E-07 |
| Normal-vs-Female |
5.020400E-04 |
| Male-vs-Female |
1.781510E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.583580E-03 |
| Normal-vs-Age(41-60Yrs) |
8.34960000029028E-07 |
| Normal-vs-Age(61-80Yrs) |
1.035490E-03 |
| Normal-vs-Age(81-100Yrs) |
2.401900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.104800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.656800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.947200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.975400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.140200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.918800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.714600E-01 |
| Classical-VS-Follicular |
9.627800E-01 |
| Classical-VS-Other |
3.659900E-02 |
| Classical-VS-Normal |
1.577230E-04 |
| Tall-VS-Follicular |
5.657400E-01 |
| Tall-VS-Other |
2.752800E-01 |
| Tall-VS-Normal |
1.157980E-03 |
| Follicular-VS-Other |
6.280300E-02 |
| Follicular-VS-Normal |
1.618150E-02 |
| Other-VS-Normal |
9.385900E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.358270E-04 |
| Normal-vs-N1 |
4.589900E-04 |
| N0-vs-N1 |
4.866800E-01 |
|
|
